台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    89.9
  • 漲跌
    ▼1.3
  • 漲幅
    -1.43%
  • 成交量
    417
  • 產業
    上櫃 生技醫療類股
  • 310人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
智擎 (4162)籌碼相關-元大-敦南 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/2207/0607/2208/0208/1608/3009/1409/2810/1210/2611/0811/2212/0612/2001/0401/1802/0802/2203/0805/1805/2803/2004/0104/1404/2405/06708090100110Jul '24Sep '24Nov '24Jan '25Mar '25May '2560d90dAll

元大-敦南 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/233.692.4100.0092.403.61,1200.32%
2025/05/2000.00592.3492.40-51,182-0.42%
2025/05/19791.501192.2291.40-41,189-0.34%
2025/05/16390.8000.0090.9031,2090.25%
2025/05/14291.6000.0091.6021,2580.16%
2025/05/13690.70692.0089.8001,2660.00%
2025/05/121690.981089.7690.6061,2980.46%
2025/05/08990.07489.7089.6051,4150.35%
2025/05/07187.00686.8887.70-51,473-0.34%
2025/05/06387.90686.7087.70-31,657-0.18%
2025/05/052087.862086.2487.7001,7640.00%
2025/05/02290.6000.0089.7021,7760.11%
2025/04/3000.00290.1089.20-21,796-0.11%
2025/04/281489.4100.0090.50141,7900.78%
2025/04/2500.00488.6087.90-41,779-0.22%
2025/04/22186.2000.0085.5011,7770.06%
2025/04/2100.001287.8985.80-121,775-0.68%
2025/04/17688.2200.0089.4061,7920.33%
2025/04/1600.00587.6087.10-51,817-0.28%
2025/04/15987.3400.0089.2091,8280.49%
2025/04/1400.00884.8085.10-81,833-0.44%
2025/04/11184.9000.0084.0011,8420.05%
2025/04/091479.041479.6176.5001,8440.00%
2025/04/081182.55582.1684.6061,8010.33%
2025/04/0200.00698.6098.80-61,770-0.34%
2025/04/0100.00198.2097.30-11,773-0.06%
2025/03/31297.2500.0096.2021,7710.11%
2025/03/261104.501105.50104.5001,7230.00%
2025/03/251106.5000.00104.5011,7190.06%
2025/03/131103.5000.00103.5011,7070.06%
2025/03/116106.5000.00107.0061,6970.35%
2025/03/1000.006106.00107.00-61,686-0.36%
2025/03/071107.0000.00107.5011,6650.06%
2025/03/063112.336112.50111.00-31,647-0.18%
2025/03/053115.5000.00115.5031,6450.18%
2025/03/041112.501113.50114.5001,6340.00%
2025/03/031113.501113.50112.5001,6200.00%
2025/02/277110.435109.30109.0021,5680.13%
2025/02/2600.004120.13115.50-41,553-0.26%
2025/02/2500.001113.00113.00-11,443-0.07%
2025/02/243115.003114.00115.0001,4310.00%
2025/02/212113.0000.00113.0021,4120.14%
2025/02/1800.0014109.00110.00-141,401-1.00%
2025/02/132112.005110.50111.50-31,413-0.21%
2025/02/126111.503112.00112.0031,4080.21%
2025/02/114109.7500.00109.0041,3920.29%
2025/02/101119.501121.00118.5001,3370.00%
2025/02/078118.001.5118.83120.506.51,3510.48%
2025/02/0610.5118.988119.75119.002.51,3290.19%
2025/02/052112.255108.80113.00-31,194-0.25%
2025/02/042104.001103.00103.0011,2010.08%
2025/01/17194.80193.2093.2001,3640.00%
2025/01/16394.90294.9595.1011,3860.07%
2025/01/15195.30193.1093.1001,3800.00%
2025/01/14195.80196.3096.1001,3720.00%
2025/01/13197.4000.0096.3011,3700.07%
2025/01/082103.000.3103.16103.001.71,2990.13%
2025/01/0700.001101.50101.50-11,275-0.08%
2025/01/03197.30297.8098.30-11,240-0.08%
2025/01/02195.400.294.3093.600.81,2350.07%
2024/12/1100.00191.8090.60-11,193-0.08%
2024/12/0300.00194.4094.40-11,161-0.09%
2024/12/0200.00394.9094.40-31,158-0.26%
2024/11/2900.000.197.9097.50-0.11,136-0.01%
2024/11/271396.3500.0094.10131,0951.19%
2024/11/1900.00097.0096.0001,0150.00%
2024/11/18199.502496.3196.50-231,010-2.28%
2024/11/136106.5000.00106.5069460.63%
2024/11/125101.841100.50104.0049160.44%
2024/11/071105.002103.50103.50-1852-0.12%
2024/11/063104.172104.75102.5018260.12%
2024/11/052.5103.003103.50106.00-0.5782-0.06%
2024/11/045102.7024100.81100.00-19758-2.50%
2024/11/0121110.811105.05105.00207302.74%
2024/10/3000.002100.75102.00-2617-0.32%
2024/10/291100.501100.50100.5006040.00%
2024/10/25198.10198.2097.4005130.00%
2024/10/240.199.00198.8098.30-0.9494-0.18%
2024/10/2200.00186.6086.70-1404-0.25%
2024/10/08491.88393.4091.1015070.20%
2024/09/2700.00187.3087.80-1556-0.18%
2024/09/20288.2500.0087.4026440.31%
2024/08/23185.5000.0085.9017400.14%
2024/08/20187.0000.0085.8017420.13%
2024/08/0500.00183.5083.00-1764-0.13%
2024/08/01294.80294.1094.5007360.00%
2024/07/3100.00393.6393.20-3736-0.41%
2024/07/30193.9000.0093.6017360.14%
2024/07/2900.00195.3094.50-1736-0.14%
2024/07/23393.67393.8394.5007200.00%
2024/07/22292.151292.1592.00-10718-1.39%
2024/07/18298.9000.0099.4026760.30%
2024/07/1100.00195.9095.20-1650-0.15%
2024/07/1000.00196.6096.60-1658-0.15%
2024/07/0811100.501299.75100.50-1655-0.15%
2024/07/04196.6000.0096.0016260.16%
2024/07/0200.00198.7097.80-1623-0.16%
2024/07/01199.7000.00101.0016100.16%
2024/06/13197.4000.0096.9016510.15%
2024/06/07193.5000.0094.5016440.16%
2024/06/0500.00293.1092.90-2632-0.32%
2024/06/04291.95291.4590.8006470.00%
2024/06/03190.80290.5090.70-1693-0.14%
2024/05/3000.00091.2090.3007370.00%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-2025/03/03
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章